首页
订购/客服:400-666-5481

JNJ-17203212

    
99.40%

4-[3-(Trifluoromethyl)-2-pyridinyl]-N-[5-(trifluoromethyl)-2-pyridinyl]-1-piperazinecarboxamide

源叶(MedMol)
S86605 一键复制产品信息
821768-06-3
C17H15F6N5O
419
JNJ 17203212;1-PiperazinecarboxaMide, 4-[3-(trifluoroMethyl)-2-pyridinyl]-N-[5-(trifluoroMethyl)-2-pyri
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
S86605-5mg买3赠1
99.40%

¥300.00

>10 - - - -
S86605-10mg买3赠1
99.40%

¥400.00

>10 - - - -
S86605-25mg买3赠1
99.40%

¥740.00

>10 - - - -
S86605-50mg买3赠1
99.40%

¥1250.00

>10 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述:

JNJ-17203212 is a selective, potent and competitive TRPV1 antagonist. JNJ-17203212 is developed for researching pain management, such as migraine

靶点: TRPV1;TRP/TRPVChannel
体内研究: JNJ-17203212 (0.3 mg/kg; i.v.) dose-dependently reduces inflammatory soup (IS)-induced the immediate early gene c-fos expression. JNJ-17203212 completely blocks capsaicin-induced CGRP (the neurotransmitter calcitonin gene-related peptide) release in a dose-dependent manner. Animal Model: Male Sprague-Dawley rats (260-300 g) Dosage: 0.3 mg/kg Administration: Intravenous injection Result: Had a dose-dependent effect on the elevated c-fos expression that occurred after intracisternal injection of IS.
参考文献: 1. Xingjuan Chen, et al. Furanocoumarins are a novel class of modulators for the transient receptor potential vanilloid type 1 (TRPV1) channel.J Biol Chem. 2014 Apr 4; 289(14): 9600-9610. 2. Jannis E Meents, et al. Two TRPV1 receptor antagonists are effective in two different experimental models of migraine. J Headache Pain. 2015; 16: 57.
溶解性: Soluble  in  DMSO
保存条件: -20℃
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 2.387 ml 11.933 ml 23.866 ml
5 mM 0.477 ml 2.387 ml 4.773 ml
10 mM 0.239 ml 1.193 ml 2.387 ml
50 mM 0.048 ml 0.239 ml 0.477 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×